Testing the feasibility of mobile ecological momentary assessment for symptom burden and management among metastatic cancer patients.
Theodore M BraskyAlison M NewtonJulie A StephensScott A StrasselsRoberto M BenzoJohn L HaysErin StevensTheodore L WagenerDonald HedekerJessica L Krok-SchoenPublished in: Digital health (2024)
adherence and retention objectives, indicating that mobile EMA is feasible among metastatic cancer patients, addressing a gap in the existing literature and informing future research. Restricting eligibility to participants with a minimum cutoff of symptom burden may be warranted to increase observations of symptom variability and provide opportunities for future health interventions. Future research is needed to test the acceptability and quality of data over a longer study period in this patient population.